PolyNovo Limited (CALZF) Research

PolyNovo Limited is a global innovator in the medical device sector, with operations and market presence spanning the United States, Australia, New Zealand, the United Kingdom, Ireland, and Singapore. The company's flagship product is the NovoSorb Biodegradable Temporising Matrix (BTM), an advanced material designed for application in meticulously cleaned surgical wounds to facilitate natural physiological closure. Beyond this core offering, PolyNovo is actively developing a diverse pipeline of new products. These include devices engineered for hernia repair and tissue reinforcement, the NovoSorb Dermal Beta Cell Implant, intended to serve as a host for pancreatic islets within the skin, and NovoSorb drug elution depots for controlled medication delivery. Established in 1998, the company originally operated under the name Calzada Limited before rebranding to PolyNovo Limited in November 2014. Its corporate headquarters are situated in Port Melbourne, Australia.

Open PolyNovo Limited (CALZF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.